$VOR insider trading
Over the last 12 months, Vor Biopharma insiders reported no purchases and 17 sales totaling $98.9M across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $98.9M 17 events
- Events · 12m
- 17 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | RA CAPITAL MANAGEMENT, L.P.10% | ▼ Sale | 213 | $19.75 | $4K | — | indirect |
| Apr 22, 2026 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▼ Sale | 165,150 | $15.77 | $2.6M | -6.4% | indirect |
| Apr 20, 2026 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▼ Sale | 630,374 | $16.14 | $10.2M | -19.7% | 2 tranches · indirect |
| Apr 15, 2026 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▼ Sale | 737,989 | $16.1 | $11.9M | -18.8% | 3 tranches · indirect |
| Apr 10, 2026 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▼ Sale | 620,133 | $16.5 | $10.2M | -13.6% | 4 tranches · indirect |
| Apr 6, 2026 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▼ Sale | 849,257 | $17.1 | $14.5M | -15.7% | 5 tranches · indirect |
| Dec 5, 2025 | Mahatme SandeshCFO · O | ▽ Sale to issuer | 694,137 | — | — | -100% | — |
| Oct 30, 2025 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▼ Sale | 400,408 | $25.9 | $10.4M | -33.9% | 4 tranches · indirect |
| Oct 27, 2025 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▼ Sale | 221,166 | $28.06 | $6.2M | -15.8% | 3 tranches · indirect |
| Oct 21, 2025 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▼ Sale | 117,050 | $29.34 | $3.4M | -7.7% | 5 tranches · indirect |
| Oct 21, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 37,533 | $30.19 | $1.1M | -3.1% | 4 tranches |
| Oct 17, 2025 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▼ Sale | 464,025 | $29.54 | $13.7M | -96.8% | 16 tranches · indirect |
| Oct 16, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 73,676 | $31.88 | $2.3M | -5.8% | 4 tranches |
| Oct 14, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 96,657 | $31.08 | $3.0M | -7% | 4 tranches |
| Oct 9, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 124,146 | $33.16 | $4.1M | -8.3% | 4 tranches |
| Oct 7, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 98,387 | $36.12 | $3.6M | -6.2% | 4 tranches |
| Oct 3, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 41,752 | $39.43 | $1.6M | -2.5% | 8 tranches |
| Sep 16, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 447,278 | $1.54 | $689K | -1.3% | — |
| Sep 15, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 984,805 | $1.73 | $1.7M | -2.9% | 3 tranches |
| Sep 10, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 1,263,647 | $1.95 | $2.5M | -3.6% | 3 tranches |
| Sep 5, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 1,407,628 | $1.97 | $2.8M | -3.8% | 3 tranches |
| Aug 28, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 1,417,998 | $2.01 | $2.8M | -3.7% | 2 tranches |
| Aug 26, 2025 | Reprogrammed Interchange LLC10% | ▼ Sale | 671,536 | $2.1 | $1.4M | -1.7% | 2 tranches |
Every $VOR filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Vor Biopharma filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $VOR feed.